Navigation Links
Glucosamine Fails Osteoarthritis Test
Date:10/20/2009

Popular supplement doesn't prevent loss of cartilage in knee, study finds

TUESDAY, Oct. 20 (HealthDay News) -- Glucosamine takes a hit in a new study that finds it doesn't prevent cartilage loss in people with osteoarthritis of the knee, University of Pittsburgh researchers report.

Many arthritis sufferers take glucosamine supplements in an attempt to reduce pain or to slow the disease's progression, but previous studies have questioned its effectiveness.

In this new study, Dr. C. Kent Kwoh, professor of medicine and epidemiology in the university's division of rheumatology and clinical immunology, had 201 people with mild to moderate knee pain randomly assigned to receive glucosamine or placebo. The study participants underwent MRI and X-ray screening at the start of the trial and 24 weeks later.

Kwoh's group found the same progression of cartilage damage in those who received glucosamine as in those who received placebo. Worsening bone lesions were also the same for both groups, and there was no difference in cartilage synthesis between the groups, the researchers noted.

The result of the study is "not surprising," said Dr. Carlos Lozada, an associate professor of rheumatology and immunology at the University of Miami Leonard M. Miller School of Medicine, who was familiar with the study.

"The larger studies that have been done to date looking at cartilage preservation using glucosamine have essentially been negative," Lozada said.

These new results were scheduled to be presented Tuesday at the American College of Rheumatology Annual Scientific Meeting, held Oct. 17 to 21 in Philadelphia.

"In this six-month study using state-of-the-art MR imaging, we were not able to demonstrate any benefit of glucosamine on the prevention of worsening joint damage in individuals with mild to moderate knee pain," Kwoh said in a prepared statement.

Osteoarthritis, the most comm
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Joint Juice Launches New Ready-to-Drink Glucosamine & Vitamin-Enhanced Dietary Supplement Water Nationwide
2. Study Suggests Glucosamine Wont Ease Hip Arthritis
3. Pharma Base S.A. Launches Osamine(TM) Pharmaceutical Grade Glucosamine in North America
4. Studies Struggle to Gauge Glucosamines Worth
5. Federal research plan to determine nanotech risks fails to deliver
6. States HMO Report Card Fails in Meaningful Evaluation of Health Care Quality and Ignores Affordability
7. Emergency Care for Heart Attacks, Pneumonia Fails to Meet Goals
8. Experimental Drug Fails Against Heart Failure
9. NSAID Drug Therapy Fails to Ease Back Pain
10. MedPAC Again Fails to Evaluate Overall Economic Conditions in Assessing SNF Funding Requirements
11. Steroid Fails to Ease Meningitis in Trials

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ERSPRING,Md.,Nov.25/PRNewswire-USNewswire/--Anarti...rDrugEvaluationandResearch,titled"ADifficultBalanc...eNov.26,2009issueofTheNewEnglandJournalofMedicine....20090824/FDALOGO ) ,, Inthearticle,Woodcockdisc...medicationforthosewhoneeditandmanagingtheriskspose...
(Date:11/25/2009)...s have found evidence of a statistically significa...patients whose estrogen receptor (ER)-positive tum...; at serine-118 (ER-alpha S118-P), according to a ...n the Journal of the National Cancer Institute . ...istant to tamoxifen. Preclinical studies have show...
(Date:11/25/2009)... Evaluation and treatment clinics to ...Woodstock (Vocus) November 25, 2009 -- Centegra He...ines and H1N1 vaccine shots at four Centegra Prima...ipment of vaccine has arrived. The clinics are at ...McHenry and will be open as follows: ,   ...
(Date:11/25/2009)...NGTON,Va.,Nov.25/PRNewswire-USNewswire/--TheAmeric...thCareFraudActof2009,"S.2128,whichisdesignedtosubs...tfraudinMedicare.ThebillwasintroducedbySen.GeorgeL...lprovisionstheAmericanAssociationforHomecareoutlin...ationproposedtoCongressinFebruary.Thoseprovisionsi...
(Date:11/25/2009)...ks placed under the skin kill tumor cells, study f...ews) -- A cancer vaccine delivered in a fingernail...a new study reports. , The method uses polymer ...d with tumor-specific antigens and implanted under... tumors. The Harvard University scientists who dev...
Breaking Medicine News(10 mins):Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2
...tial financial income and the c...ime is a precious commodity, and so,people are inc... their,time, especially when it comes to financial...rgest online and catalog companies catering,exclus...
...ior Management Team, NASHVILLE, Tenn., May 20 Em...nue cycle management and clinical communication,so...as been named Senior,Vice President of Corporate S...ntly, Ms. Paramore was a,Partner with Commonwealth...
...fits of,lipid-modifying drugs, current management ...n a new supplement to The Journal of Family,Practi... in aggressive,lipid lowering" reviews the evidenc... patients., "High-dose statin therapy: Benefits a...
...in key organs , , TUESDAY, May 20 (HealthD...lso protect against adenovirus, which causes upper...uses that causes the common cold. , Currently, the...hing that needs to be done before new drugs can be...
...oomers,have challenged many industries to replace ...the multi-generational workforce is challenging,co...s to engage employees,and to define a new type of ...long,term strategies through dynamic case study pr...
...s with latent tuberculosis (TB), who are infected ...t it in less than half the time and at a lower cos...o researchers who conducted a multi-center, random... We found that using a therapy of four months of R...
Other Medicine News:Health News:Lucrative Sales Opportunities Abound With Melaleuca, The Wellness Company(R) 2Health News:Emdeon Business Services Names Miriam Paramore Senior Vice President of Corporate Strategy 2Health News:Reductions in CV Morbidity and Mortality are Achievable! 2Health News:Smallpox Drug May Protect Against Common Cold 2Health News:Fortune 500s to Convene in Florida, Sharing Insights & Best Practices for Developing Tomorrow's Leaders 2Health News:Rifampin: Latent TB treatment saves time money and lives 2
(Date:11/25/2009)...swire/--AccordingtoMillenniumResearchGroup(MRG),th...nce,thenearly$3billionUSmarketfortraumafixationdev...rsdespitetherecenteconomicslowdown.MRG,s USMarkets...llremainhighlydynamicoverthenextfiveyears,withcomp...derservedsegmentsofthetraumafixationmarket,fueling...
(Date:11/25/2009)...ANNESBURG,November25/PRNewswire/--,iThembaPharmace...oday,thattheyhavesignedacollaborativeagreementtojo...worldclasscomputationalchemistryandleaddiscoveryex...oprovidemedicinaland,syntheticchemistrysupporttopr...etwork.iThembaPharmaceuticalsandPyxisDiscovery,als...
(Date:11/24/2009)...swire-FirstCall/--Endologix,Inc.(Nasdaq: ELGX ),de...ders,announcedtodaythatithasfiledamotiontostay,ord...wsuitbroughtagainstitinOctober2009byCook,Inc.Themo...apolis,Indiana. ,, Endologixhasrequestedthatthe...demarkOffice(USPTO)conductsproceedingstore-examine...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2BioFit Intensive Plus 26amp 3B 238482 3B Chairs Meet Federal Standard for Continuous Intensive Use 48720 1BioFit Intensive Plus 26amp 3B 238482 3B Chairs Meet Federal Standard for Continuous Intensive Use 48720 2BioFit Intensive Plus 26amp 3B 238482 3B Chairs Meet Federal Standard for Continuous Intensive Use 48720 3Manatees can probably hear which directions boats approach from 8808 1Manatees can probably hear which directions boats approach from 8808 2Hey Governator 21 Dont Terminate Senior Funding 21 48717 1Hey Governator 21 Dont Terminate Senior Funding 21 48717 2Hey Governator 21 Dont Terminate Senior Funding 21 48717 3Hey Governator 21 Dont Terminate Senior Funding 21 48717 4Hey Governator 21 Dont Terminate Senior Funding 21 48717 5
...t, a division of Rigaku,Americas Corporation, anno...-based Lead Discovery (FBLD) Project with CHDI, In..."fragments," to the,active sites of protein drug t...mpounds used in traditional high-throughput screen...hemical space with a smaller screening,library. Ut...
...,multi-disciplinary group of researchers from the ...rsity of Maryland Biotechnology Institute (UMBI),h...Foundation (NSF) grant,to revolutionize the way re... The group, led by William Bentley, Herbert Rabin ...Department of Bioengineering at the,University of ...
Other Medicine Technology:ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies 2ActiveSight and CHDI Leverage Fragment-Based Lead Discovery for Huntington Disease Therapies 3U. of Md. Researchers to Develop Devices to Revolutionize Drug Research 2U. of Md. Researchers to Develop Devices to Revolutionize Drug Research 3U. of Md. Researchers to Develop Devices to Revolutionize Drug Research 4U. of Md. Researchers to Develop Devices to Revolutionize Drug Research 5
RIDASCREEN Anti-VZV IgM Assay
...ricella- Zoster Virus (VZV) IgG Enzyme- linked Imm...tion and quantitative determination of IgG antibod... may be used for the determination of immune statu...d to demonstrate seroconversion or a significant r...
...nzyme-Linked Immunosorbent Assay (ELISA) is intend...n of IgG antibody to VZV in human sera. Individua...n of immune status. Paired sera, acute and convale...r a significant rise in antibody level, as an aid ...
RIDASCREEN Anti-Mumps Virus IgM Assay
Medicine Products: